|
市場調查報告書
偏頭痛市場預測
Migraine Market Forecast
|
偏頭痛市場預測 是由出版商Datamonitor在2010年07月所出版的。
這份英文市場調查報告書價格從美金15200起跳。
本報告針對偏頭痛治療藥物目前與將來市場預測規模定量化，提供2010到2019年全球七大醫藥用品市場各國偏頭痛治藥物的成長與影響波及的主要活動、後期實驗產品上市後的影響及相關調查，目錄介紹如下。
概要
預測方法
免責事項
Abstract
Introduction
After 4 years of steady growth, the migraine market across the seven major regions was valued at $4.6 billion in 2008. However, following US patent expiries of both the acute migraine market leading brand, Imitrex (sumatriptan; GlaxoSmithKline), and leading prophylactic Topamax (topiramate; Johnson & Johnson), the market value plummeted by almost $1.5 billion from 2008 to $3.6 billion in 2009.
Reasons to Purchase
- Quantify the current and future size of the migraine market.
- Understand the country-specific impact of key events in the migraine market during the forecast period 2010 to 2019.
- Understand when late-stage pipeline products will launch and what impact these will have on the market during the forecast period 2010 to 2019.
Table of Contents
OVERVIEW
- This product contains forecasts for anti-migraine drugs across the seven major markets from 2010 to 2019. It has been designed for delivery in an excel data pack format..
- The associated report and PowerPoint presentation can be found under Latest research in the Knowledge centre, through the search function or by contacting your sales representative.
- Introduction
- Scope of this research
- Research and analysis highlights
- Key reasons to read this report
- Forecasting Methodology
- The forecasting model:
- General event information:
- Event selection and quantification:
- Event parameters:
- Disclaimer
|
